SCHEMBL28528446

SCHEMBL28528446

CC1CCN(C(=O)c2ccc(OC(F)(F)F)cc2)C1(COCc1ccccc1)C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM5 P08912 3/20 0.42
CHRM2 P08172 1/20 0.41
CHRM1 P11229 1/20 0.41
SCN9A Q15858 2/20 0.40
TP53 P04637 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HRH3 Q9Y5N1 2/20 0.39
FAAH O00519 1/20 0.39
EPHX2 P34913 1/20 0.39
HSD11B1 P28845 1/20 0.39
CA2 P00918 1/20 0.39
ENPP2 Q13822 2/20 0.39
ATXN2 Q99700 1/20 0.39
CHRM4 P08173 1/20 0.38
MGLL Q99685 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28528445 1.00 CHRM5 (0.42) CHRM5CHRM2CHRM1SCN9ATP53
SCHEMBL28522822 0.78 CHRM5 (0.43) CHRM5TP53CYP3A4CYP2C9TSHR
SCHEMBL28545922 0.77 SMN1; SMN2 (0.38) CYP2C19SMN1; SMN2FAAH
SCHEMBL28523651 0.76 KCNH2 (0.43) HRH3
SCHEMBL28523650 0.76 KCNH2 (0.43) HRH3
SCHEMBL28528444 0.75 CYP3A4 (0.46) CHRM5TP53CYP3A4CYP2C9TSHR
SCHEMBL28907976 0.75 SMN1; SMN2 (0.42) SMN1; SMN2
SCHEMBL28907975 0.75 SMN1; SMN2 (0.42) SMN1; SMN2
SCHEMBL28991793 0.73 TACR1 (0.42) CHRM2CHRM1TSHR
SCHEMBL20831002 0.66 KMT2A (0.67) TP53SMN1; SMN2TDP1FAAHEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112174869-A Preparation method and medicinal application of N-phenylacetyl-2-hydroxymethyl pyrrolidine-2-formamide 蔡霈 2021-01-05 CN disclosed